ÂÜÀòÂÒÂ×

Eva Chin is the Inaugural Executive Director of Solve FSHD, a venture philanthropic organization based in Vancouver focused on accelerating research for a cure for facioscapulohumeral muscular dystrophy (FSHD) since September 2021. Previously, Eva Chin served as a consultant and Chief Development Officer at NMD Pharma A/S and held senior roles at Cytokinetics, including Senior Director of Pharmacology & Non-clinical Safety and Director of Pharmacology, contributing to the development of muscle activators for serious muscle disorders. Prior experience includes serving as Chief Scientific Officer at Myotherapeutics LLC, focusing on chronic muscle disorders, as well as an Assistant Professor at the University of Maryland and various roles at Pfizer. Eva Chin's academic credentials include a PhD in Physiology from the University of Waterloo and a Certificate of Entrepreneurship from The Johns Hopkins University.